MEK1/2 kinases disable the tumor suppressor functions of native BCR and ABL1 kinases to impair anticancer drugs’ responsiveness in TKI-resistant Philadelphia positive leukemias

Congress of the Italian Society of Experimental Hematology (18th : Firenze, Italy : March 7-9, 2024)

Haematologica . – Vol. 109 s1 (2024) . – p s66-s67 (P019)

ultimo accesso 05/12/2024 https://haematologica.org/issue/view/haematol.2024.s1

Nr. Estr. 9779